PIK3CA and maternal uniparental disomy of chromosome 20: For instance, when coupled with fulvestrant, the specific PIK3CA inhibitor Alpelisib has shown promising treatment efficiency in recently approved in ER-positive mBCs patients who had received endocrine therapy previously (12).